XTANT MEDICAL HOLDINGS, INC. Accounts and Financing Receivable, Allowance for Credit Loss
XTANT MEDICAL HOLDINGS, INC. (XTNT) had Accounts and Financing Receivable, Allowance for Credit Loss of $2.23 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:AccountsAndFinancingReceivableAllowanceForCreditLoss · last filed 2026-08-11
- 2026-06-30: Accounts and Financing Receivable, Allowance for Credit Loss $2.23M.
- 2026-03-31: Accounts and Financing Receivable, Allowance for Credit Loss $2.12M.
- 2025-12-31: Accounts and Financing Receivable, Allowance for Credit Loss $2.17M.
- 2025-09-30: Accounts and Financing Receivable, Allowance for Credit Loss $2.02M.
| Period end | Accounts and Financing Receivable, Allowance for Credit Loss | Accounts and Financing Receivable, Allowance for Credit Loss as first filed |
|---|---|---|
| 2026-06-30 | $2.23M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $2.12M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.17M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $2.02M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.79M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.71M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.44M 10-K · filed 2026-03-31 | |
| 2023-12-31 | $900.00K 10-K · filed 2026-03-31 | $920.00K 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |